{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:31:55Z","timestamp":1782246715821,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81773109\uff0c82273410"],"award-info":[{"award-number":["81773109\uff0c82273410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Province Capability Improvement Project through Science\uff0cTechnology and Education","award":["JSDW202248"],"award-info":[{"award-number":["JSDW202248"]}]},{"name":"the Fund of the priority Academic Program Development of Jiangsu Higher Education Institution","award":["JX1023-1801"],"award-info":[{"award-number":["JX1023-1801"]}]},{"name":"the National key Clinical Specialty Construction Project","award":["2014"],"award-info":[{"award-number":["2014"]}]},{"name":"Joint key project funded by Southeast University and Nanjing Medical University","award":["2242019K3DN09, 2019DN0011"],"award-info":[{"award-number":["2242019K3DN09, 2019DN0011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current diagnostic criteria of adrenocortical neoplasms are mostly based on morphology. The utility of immunohistochemistry (IHC) and histochemistry is limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>To evaluate the diagnostic and prognostic utility of clinicopathological features, morphology, ancillary biomarkers, and reticular histochemistry in adrenocortical neoplasms. We examined 28 adrenocortical carcinomas (ACCs) and 50 adrenocortical adenomas (ACAs) obtained from pathology archives. Clinical data were retrieved from medical records. Two pathologists independently assessed hematoxylin and eosin-stained slides, employing modified Weiss criteria for all tumors and Lin-Weiss-Bisceglia criteria for oncocytic variants. Immunohistochemical markers (Calretinin, alpha-inhibin, MelanA, SF-1, Ki-67, PHH3, IGF-2, \u03b2-catenin, P53, CYP11B1, CYP11B2, MLH1, MSH2, MSH6, PMS2, EPCAM) and Gomori\u2019s Silver histochemistry were applied. Statistical analysis utilized SPSS Statistics 26.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ACCs exhibited larger tumor sizes (<jats:italic>P<\/jats:italic>&lt;0.001) and symptomatic presentations (<jats:italic>P<\/jats:italic>\u2009=\u20090.031) compared to ACAs. Parameters of modified Weiss criteria and angioinvasion demonstrated diagnostic value for ACCs. Six immunohistochemical antibodies((MelanA, Ki-67, IGF-2, \u03b2-catenin, P53 and CYP11B1) and reticulin framework alterations showed diagnostic value. Notably, Ki-67 and reticulin staining were most recommended. Evident reticulin staining was frequently present in ACCs (<jats:italic>P<\/jats:italic>&lt;0.001). Ki-67 was significantly higher in ACCs (<jats:italic>P<\/jats:italic>&lt;0.001). Twenty-one conventional and seven oncocytic entities showed different necrosis frequencies. Symptoms and Ki-67 index\u2009\u2265\u200930% were prognostic for ACCs, correlating with shorter survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study emphasizes the diagnostic value of reticulin framework alterations and a high Ki-67 index. Markers such as CYP11B1, IGF2, P53, \u03b2-catenin and MelanA also contribute to the diagnosis of ACCs. Symptoms and Ki-67 index\u2009\u2265\u200930% predict shorter survival. These findings encourges the use of ancillary markers such as reticulin histochemistry and Ki-67 in the workup of evaluations of adrenocortical neoplasms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-024-01496-z","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:02:40Z","timestamp":1716822160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining"],"prefix":"10.1186","volume":"19","author":[{"given":"Wenting","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"issue":"4","key":"1496_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.path.2019.08.005","volume":"12","author":"A Hodgson","year":"2019","unstructured":"Hodgson A, Pakbaz S, Mete O. A Diagnostic Approach to Adrenocortical Tumors. Surg Pathol Clin. 2019;12(4):967\u201395.","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"1496_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/PAS.0000000000000943","volume":"42","author":"O Mete","year":"2018","unstructured":"Mete O, Gucer H, Kefeli M, Asa SL. Diagnostic and prognostic biomarkers of adrenal cortical carcinoma. Am J Surg Pathol. 2018;42(2):201\u201313.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1496_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Erickson LA, Juhlin CC, et al. Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol. 2022;33(1):155\u201396.","journal-title":"Endocr Pathol"},{"issue":"3","key":"1496_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","volume":"13","author":"LM Weiss","year":"1989","unstructured":"Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13(3):202\u20136.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1496_CR5","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/01.MP.0000081730.72305.81","volume":"16","author":"A Stojadinovic","year":"2003","unstructured":"Stojadinovic A, Brennan MF, Hoos A, et al. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis. Mod Pathol. 2003;16(8):742\u201351.","journal-title":"Mod Pathol"},{"key":"1496_CR6","doi-asserted-by":"publisher","first-page":"1134643","DOI":"10.3389\/fendo.2023.1134643","volume":"14","author":"LH Pan","year":"2023","unstructured":"Pan LH, Yen CC, Huang CJ, et al. Prognostic predictors of adrenocortical carcinoma: a single-center thirty-year experience. Front Endocrinol (Lausanne). 2023;14:1134643.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1496_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00428-011-1166-y","volume":"460","author":"RR de Krijger","year":"2012","unstructured":"de Krijger RR, Papathomas TG. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants. Virchows Arch. 2012;460(1):9\u201318.","journal-title":"Virchows Arch"},{"issue":"6","key":"1496_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/PAP.0000000000000209","volume":"25","author":"SE Higgins","year":"2018","unstructured":"Higgins SE, Barletta JA. Applications of immunohistochemistry to Endocrine Pathology. Adv Anat Pathol. 2018;25(6):413\u201329.","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"1496_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","volume":"29","author":"O Mete","year":"2018","unstructured":"Mete O, Asa SL, Giordano TJ, et al. Immunohistochemical biomarkers of adrenal cortical neoplasms. Endocr Pathol. 2018;29(2):137\u201349.","journal-title":"Endocr Pathol"},{"issue":"9","key":"1496_CR10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/modpathol.2013.230","volume":"27","author":"E Duregon","year":"2014","unstructured":"Duregon E, Molinaro L, Volante M, et al. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma. Mod Pathol. 2014;27(9):1246\u201354.","journal-title":"Mod Pathol"},{"issue":"5","key":"1496_CR11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.4103\/ijem.IJEM_573_16","volume":"21","author":"D Fonseca","year":"2017","unstructured":"Fonseca D, Murthy SS, Tagore KR, et al. Diagnosis of adrenocortical tumors by Reticulin Algorithm. Indian J Endocrinol Metab. 2017;21(5):734\u20137.","journal-title":"Indian J Endocrinol Metab"},{"key":"1496_CR12","doi-asserted-by":"crossref","unstructured":"Bonneville R, Krook MA, Kautto EA et al. Landscape of microsatellite instability across 39 Cancer types. JCO Precis Oncol. 2017;2017:PO.17.00073.","DOI":"10.1200\/PO.17.00073"},{"issue":"4","key":"1496_CR13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/clinem\/dgab866","volume":"107","author":"MR Clay","year":"2022","unstructured":"Clay MR, Pinto EM, Fishbein L, et al. Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma. J Clin Endocrinol Metab. 2022;107(4):1159\u201369.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1496_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","volume":"55","author":"M Volante","year":"2009","unstructured":"Volante M, Bollito E, Sperone P, et al. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. Histopathology. 2009;55(5):535\u201343.","journal-title":"Histopathology"},{"issue":"9","key":"1496_CR15","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/PAS.0b013e31828d387b","volume":"37","author":"E Duregon","year":"2013","unstructured":"Duregon E, Fassina A, Volante M, et al. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases. Am J Surg Pathol. 2013;37(9):1433\u201340.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1496_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/jpm11030208","volume":"11","author":"A Angelousi","year":"2021","unstructured":"Angelousi A, Kyriakopoulos G, Athanasouli F, et al. The role of immunohistochemical markers for the diagnosis and prognosis of Adrenocortical Neoplasms. J Pers Med. 2021;11(3):208.","journal-title":"J Pers Med"},{"issue":"6","key":"1496_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1055\/a-1139-2079","volume":"52","author":"CE Gomez-Sanchez","year":"2020","unstructured":"Gomez-Sanchez CE, Gomez-Sanchez EP, Nishimoto K. Immunohistochemistry of the human adrenal CYP11B2 in normal individuals and in patients with primary Aldosteronism. Horm Metab Res. 2020;52(6):421\u20136.","journal-title":"Horm Metab Res"},{"issue":"4","key":"1496_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12672-015-0224-3","volume":"6","author":"TM Kerkhofs","year":"2015","unstructured":"Kerkhofs TM, Kerstens MN, Kema IP, et al. Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors. Horm Cancer. 2015;6(4):168\u201375.","journal-title":"Horm Cancer"},{"issue":"3","key":"1496_CR19","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1210\/clinem\/dgz141","volume":"105","author":"V Chortis","year":"2020","unstructured":"Chortis V, Bancos I, Nijman T, et al. Urine steroid Metabolomics as a Novel Tool for detection of recurrent Adrenocortical Carcinoma. J Clin Endocrinol Metab. 2020;105(3):e307\u201318.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1496_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-016-9441-8","volume":"28","author":"T Uchida","year":"2017","unstructured":"Uchida T, Nishimoto K, Fukumura Y, et al. Disorganized steroidogenesis in Adrenocortical Carcinoma, a case study. Endocr Pathol. 2017;28(1):27\u201335.","journal-title":"Endocr Pathol"},{"issue":"3","key":"1496_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s12020-019-02022-8","volume":"65","author":"Y Yang","year":"2019","unstructured":"Yang Y, Xiao M, Song Y, et al. H-score of 11\u03b2-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors. Endocrine. 2019;65(3):683\u201391.","journal-title":"Endocrine"},{"issue":"8","key":"1496_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/biomedicines8080256","volume":"8","author":"SS Pereira","year":"2020","unstructured":"Pereira SS, Costa MM, Gomez-Sanchez CE, et al. Incomplete pattern of steroidogenic protein expression in Functioning Adrenocortical Carcinomas. Biomedicines. 2020;8(8):256.","journal-title":"Biomedicines"},{"issue":"50","key":"1496_CR23","doi-asserted-by":"publisher","first-page":"e27864","DOI":"10.1097\/MD.0000000000027864","volume":"100","author":"Q Chen","year":"2021","unstructured":"Chen Q, Ren Z, Liu D, et al. Identification of prognostic metabolic genes in adrenocortical carcinoma and establishment of a prognostic nomogram: a bioinformatic study. Med (Baltim). 2021;100(50):e27864.","journal-title":"Med (Baltim)"},{"issue":"3","key":"1496_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"Beuschlein F, Weigel J, Saeger W, et al. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab. 2015;100(3):841\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1496_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/ajcp\/aqz003","volume":"151","author":"ML Khieu","year":"2019","unstructured":"Khieu ML, Broadwater DR, Aden JK, et al. The utility of phosphohistone H3 (PHH3) in follicular lymphoma grading: a comparative study with Ki-67 and H&E Mitotic Count. Am J Clin Pathol. 2019;151(6):542\u201350.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"1496_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/his.14837","volume":"82","author":"A Ibrahim","year":"2023","unstructured":"Ibrahim A, Toss MS, Makhlouf S, et al. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Histopathology. 2023;82(3):393\u2013406.","journal-title":"Histopathology"},{"issue":"4","key":"1496_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1385\/EP:12:4:429","volume":"12","author":"LA Erickson","year":"2001","unstructured":"Erickson LA, Jin L, Sebo TJ, et al. Pathologic features and expression of insulin-like growthfactor-2 in adrenocortical neoplasms. Endocr Pathol. 2001;12(4):429\u201335.","journal-title":"Endocr Pathol"},{"issue":"4","key":"1496_CR28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/his.12283","volume":"64","author":"C Wang","year":"2014","unstructured":"Wang C, Sun Y, Wu H, et al. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers. Histopathology. 2014;64(4):567\u201376.","journal-title":"Histopathology"},{"issue":"3","key":"1496_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2559.2006.02505.x","volume":"49","author":"A Schmitt","year":"2006","unstructured":"Schmitt A, Saremaslani P, Schmid S, et al. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology. 2006;49(3):298\u2013307.","journal-title":"Histopathology"},{"issue":"2","key":"1496_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","volume":"30","author":"S Zheng","year":"2016","unstructured":"Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-genomic characterization of Adrenocortical Carcinoma. Cancer Cell. 2016;30(2):363.","journal-title":"Cancer Cell"},{"issue":"9","key":"1496_CR31","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.3390\/cancers14092225","volume":"14","author":"S Hescot","year":"2022","unstructured":"Hescot S, Faron M, Kordahi M, et al. Screening for prognostic biomarkers in metastatic adrenocortical carcinoma by tissue Micro arrays analysis identifies P53 as an independent prognostic marker of overall survival. Cancers (Basel). 2022;14(9):2225.","journal-title":"Cancers (Basel)"},{"issue":"26","key":"1496_CR32","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015;372(26):2509\u201320.","journal-title":"N Engl J Med"},{"issue":"10","key":"1496_CR33","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/diagnostics10100786","volume":"10","author":"J Soboci\u0144ska","year":"2020","unstructured":"Soboci\u0144ska J, Kolenda T, Teresiak A, et al. Diagnostics of mutations in MMR\/EPCAM genes and their role in the treatment and care of patients with Lynch Syndrome. Diagnostics (Basel). 2020;10(10):786.","journal-title":"Diagnostics (Basel)"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01496-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:05:56Z","timestamp":1716822356000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01496-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01496-z","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"24 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used ChatGPT in order to improve language and readability. After using this tool\/service, the authors reviewed and edited the content as needed and takes full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}